BIO - Bio-Rad Laboratories - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BIO is currently covered by 3 analysts with an average price target of $316.88. This is a potential upside of $52.56 (19.88%) from yesterday's end of day stock price of $264.32.

Bio-Rad Laboratories's activity chart (see below) currently has 76 price targets and 53 ratings on display. The stock rating distribution of BIO is 72.73% BUY and 27.27% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.96% with an average time for these price targets to be met of 184.75 days.

Highest price target for BIO is $390, Lowest price target is $245, average price target is $317.5.

Most recent stock forecast was given by BRANDON COUILLARD from WELLS FARGO on 09-Jun-2025. First documented stock forecast 06-May-2015.

Best performing analysts who are covering BIO - Bio-Rad Laboratories:

Patrick B Donnelly Brandon Couillard Dan Leonard Jack Meehan

Currently out of the existing stock ratings of BIO, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$245

$3.05 (1.26%)

$270

1 months 29 days ago
(09-Jun-2025)

17/20 (85%)

$19.44 (8.62%)

228

Buy

$390

$148.05 (61.19%)

$385

9 months 7 days ago
(31-Oct-2024)

12/23 (52.17%)

$31.81 (8.88%)

149

Buy

$700

$295.94 (73.24%)

$750

3 years 30 days ago
(08-Jul-2022)

8/12 (66.67%)

$112.28 (23.08%)

170

Buy

$380

$21.55 (6.01%)

$340

6 years 5 days ago
(02-Aug-2019)

4/4 (100%)

$46.7 (17.50%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BIO (Bio-Rad Laboratories) average time for price targets to be met?

On average it took 184.75 days on average for the stock forecasts to be realized with a an average price target met ratio 75.96

Which analyst has the current highest performing score on BIO (Bio-Rad Laboratories) with a proven track record?

PATRICK DONNELLY

Which analyst has the current lower performing score on BIO (Bio-Rad Laboratories) with a proven track record?

JACK MEEHAN

Which analyst has the most public recommendations on BIO (Bio-Rad Laboratories)?

Patrick Donnelly works at CITI and has 15465 price targets and 12220 ratings on BIO

Which analyst is the currently most bullish on BIO (Bio-Rad Laboratories)?

Patrick Donnelly with highest potential upside - $295.94

Which analyst is the currently most reserved on BIO (Bio-Rad Laboratories)?

Brandon Couillard with lowest potential downside - $3.05

Bio-Rad Laboratories in the News

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

HERCULES, Calif., August 01, 2025–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s management will host an informational webinar on Bio-Rad’s Droplet Digital™ PCR (ddPCR™) product portfolio on Tuesday, August 26, 2025, at 10:00 AM Pacific Time (1:00 PM Eastern...

Bio-Rad Laboratories Inc (BIO) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

Net Sales: $652 million, a 2.1% increase from $638 million in Q2 2024. Life Science Group Sales: $263 million, a 4.9% increase on a reported basis. Clinical Diagnostics Group Sales: $389 million, essentially flat compared to Q2 2024. Gross Margin: 53% reported, down from 55.6% in Q2 2024. Operating Income: $77 million, 11.8% of sales,...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?